Report Detail
COVID-19 Impact on Global Embolic Agents Market Insights, Forecast to 2026
- RnM3985975 |
- 03 June, 2020 |
- Global |
- 119 Pages |
- QYResearch |
- Other
Embolic Agent is a material used to block off blood flow through a vessel.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Embolic Agents market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Embolic Agents industry.
Based on our recent survey, we have several different scenarios about the Embolic Agents YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Embolic Agents will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Embolic Agents market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Embolic Agents market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Embolic Agents market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Production and Pricing Analyses
Readers are provided with deeper production analysis, import and export analysis, and pricing analysis for the global Embolic Agents market. As part of production analysis, the report offers accurate statistics and figures for production capacity, production volume by region, and global production and production by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for price by manufacturer and price by region for the period 2015-2020 and price by each type segment for the period 2015-2026. The import and export analysis for the global Embolic Agents market has been provided based on region.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Embolic Agents market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Embolic Agents market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Embolic Agents market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Embolic Agents market.
The following manufacturers are covered in this report:
Medtronic
Terumo
Boston Scientific
Merit Medical
Johnson & Johnson
GEM Italy
IMBiotechnologies Ltd（IMB）
Emboflu
BTG
Cook Medical
Embolic Agents Breakdown Data by Type
Liquid Embolic Agents
Particulate Embolic Agents
Others
Embolic Agents Breakdown Data by Application
Occlude Bleeding
Oncotherapy
Malignant Hypertension
Others
1 Study Coverage
- 1.1 Embolic Agents Product Introduction
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered: Ranking of Global Top Embolic Agents Manufacturers by Revenue in 2019
- 1.4 Market by Type
- 1.4.1 Global Embolic Agents Market Size Growth Rate by Type
- 1.4.2 Liquid Embolic Agents
- 1.4.3 Particulate Embolic Agents
- 1.4.4 Others
- 1.5 Market by Application
- 1.5.1 Global Embolic Agents Market Size Growth Rate by Application
- 1.5.2 Occlude Bleeding
- 1.5.3 Oncotherapy
- 1.5.4 Malignant Hypertension
- 1.5.5 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Embolic Agents Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Embolic Agents Industry
- 1.6.1.1 Embolic Agents Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Embolic Agents Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Embolic Agents Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Embolic Agents Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Embolic Agents Market Size Estimates and Forecasts
- 2.1.1 Global Embolic Agents Revenue Estimates and Forecasts 2015-2026
- 2.1.2 Global Embolic Agents Production Capacity Estimates and Forecasts 2015-2026
- 2.1.3 Global Embolic Agents Production Estimates and Forecasts 2015-2026
- 2.2 Global Embolic Agents Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Global Embolic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.3.3 Global Embolic Agents Manufacturers Geographical Distribution
- 2.4 Key Trends for Embolic Agents Markets & Products
- 2.5 Primary Interviews with Key Embolic Agents Players (Opinion Leaders)
3 Market Size by Manufacturers
- 3.1 Global Top Embolic Agents Manufacturers by Production Capacity
- 3.1.1 Global Top Embolic Agents Manufacturers by Production Capacity (2015-2020)
- 3.1.2 Global Top Embolic Agents Manufacturers by Production (2015-2020)
- 3.1.3 Global Top Embolic Agents Manufacturers Market Share by Production
- 3.2 Global Top Embolic Agents Manufacturers by Revenue
- 3.2.1 Global Top Embolic Agents Manufacturers by Revenue (2015-2020)
- 3.2.2 Global Top Embolic Agents Manufacturers Market Share by Revenue (2015-2020)
- 3.2.3 Global Top 10 and Top 5 Companies by Embolic Agents Revenue in 2019
- 3.3 Global Embolic Agents Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Embolic Agents Production by Regions
- 4.1 Global Embolic Agents Historic Market Facts & Figures by Regions
- 4.1.1 Global Top Embolic Agents Regions by Production (2015-2020)
- 4.1.2 Global Top Embolic Agents Regions by Revenue (2015-2020)
- 4.2 North America
- 4.2.1 North America Embolic Agents Production (2015-2020)
- 4.2.2 North America Embolic Agents Revenue (2015-2020)
- 4.2.3 Key Players in North America
- 4.2.4 North America Embolic Agents Import & Export (2015-2020)
- 4.3 Europe
- 4.3.1 Europe Embolic Agents Production (2015-2020)
- 4.3.2 Europe Embolic Agents Revenue (2015-2020)
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Embolic Agents Import & Export (2015-2020)
- 4.4 China
- 4.4.1 China Embolic Agents Production (2015-2020)
- 4.4.2 China Embolic Agents Revenue (2015-2020)
- 4.4.3 Key Players in China
- 4.4.4 China Embolic Agents Import & Export (2015-2020)
- 4.5 Japan
- 4.5.1 Japan Embolic Agents Production (2015-2020)
- 4.5.2 Japan Embolic Agents Revenue (2015-2020)
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Embolic Agents Import & Export (2015-2020)
5 Embolic Agents Consumption by Region
- 5.1 Global Top Embolic Agents Regions by Consumption
- 5.1.1 Global Top Embolic Agents Regions by Consumption (2015-2020)
- 5.1.2 Global Top Embolic Agents Regions Market Share by Consumption (2015-2020)
- 5.2 North America
- 5.2.1 North America Embolic Agents Consumption by Application
- 5.2.2 North America Embolic Agents Consumption by Countries
- 5.2.3 U.S.
- 5.2.4 Canada
- 5.3 Europe
- 5.3.1 Europe Embolic Agents Consumption by Application
- 5.3.2 Europe Embolic Agents Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 U.K.
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Embolic Agents Consumption by Application
- 5.4.2 Asia Pacific Embolic Agents Consumption by Regions
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Taiwan
- 5.4.9 Indonesia
- 5.4.10 Thailand
- 5.4.11 Malaysia
- 5.4.12 Philippines
- 5.4.13 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Embolic Agents Consumption by Application
- 5.5.2 Central & South America Embolic Agents Consumption by Country
- 5.5.3 Mexico
- 5.5.3 Brazil
- 5.5.3 Argentina
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Embolic Agents Consumption by Application
- 5.6.2 Middle East and Africa Embolic Agents Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 Saudi Arabia
- 5.6.5 U.A.E
6 Market Size by Type (2015-2026)
- 6.1 Global Embolic Agents Market Size by Type (2015-2020)
- 6.1.1 Global Embolic Agents Production by Type (2015-2020)
- 6.1.2 Global Embolic Agents Revenue by Type (2015-2020)
- 6.1.3 Embolic Agents Price by Type (2015-2020)
- 6.2 Global Embolic Agents Market Forecast by Type (2021-2026)
- 6.2.1 Global Embolic Agents Production Forecast by Type (2021-2026)
- 6.2.2 Global Embolic Agents Revenue Forecast by Type (2021-2026)
- 6.2.3 Global Embolic Agents Price Forecast by Type (2021-2026)
- 6.3 Global Embolic Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
- 7.2.1 Global Embolic Agents Consumption Historic Breakdown by Application (2015-2020)
- 7.2.2 Global Embolic Agents Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
- 8.1 Medtronic
- 8.1.1 Medtronic Corporation Information
- 8.1.2 Medtronic Overview and Its Total Revenue
- 8.1.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.1.4 Medtronic Product Description
- 8.1.5 Medtronic Recent Development
- 8.2 Terumo
- 8.2.1 Terumo Corporation Information
- 8.2.2 Terumo Overview and Its Total Revenue
- 8.2.3 Terumo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.2.4 Terumo Product Description
- 8.2.5 Terumo Recent Development
- 8.3 Boston Scientific
- 8.3.1 Boston Scientific Corporation Information
- 8.3.2 Boston Scientific Overview and Its Total Revenue
- 8.3.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.3.4 Boston Scientific Product Description
- 8.3.5 Boston Scientific Recent Development
- 8.4 Merit Medical
- 8.4.1 Merit Medical Corporation Information
- 8.4.2 Merit Medical Overview and Its Total Revenue
- 8.4.3 Merit Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.4.4 Merit Medical Product Description
- 8.4.5 Merit Medical Recent Development
- 8.5 Johnson & Johnson
- 8.5.1 Johnson & Johnson Corporation Information
- 8.5.2 Johnson & Johnson Overview and Its Total Revenue
- 8.5.3 Johnson & Johnson Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.5.4 Johnson & Johnson Product Description
- 8.5.5 Johnson & Johnson Recent Development
- 8.6 GEM Italy
- 8.6.1 GEM Italy Corporation Information
- 8.6.2 GEM Italy Overview and Its Total Revenue
- 8.6.3 GEM Italy Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.6.4 GEM Italy Product Description
- 8.6.5 GEM Italy Recent Development
- 8.7 IMBiotechnologies Ltd（IMB）
- 8.7.1 IMBiotechnologies Ltd（IMB） Corporation Information
- 8.7.2 IMBiotechnologies Ltd（IMB） Overview and Its Total Revenue
- 8.7.3 IMBiotechnologies Ltd（IMB） Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.7.4 IMBiotechnologies Ltd（IMB） Product Description
- 8.7.5 IMBiotechnologies Ltd（IMB） Recent Development
- 8.8 Emboflu
- 8.8.1 Emboflu Corporation Information
- 8.8.2 Emboflu Overview and Its Total Revenue
- 8.8.3 Emboflu Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.8.4 Emboflu Product Description
- 8.8.5 Emboflu Recent Development
- 8.9 BTG
- 8.9.1 BTG Corporation Information
- 8.9.2 BTG Overview and Its Total Revenue
- 8.9.3 BTG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.9.4 BTG Product Description
- 8.9.5 BTG Recent Development
- 8.10 Cook Medical
- 8.10.1 Cook Medical Corporation Information
- 8.10.2 Cook Medical Overview and Its Total Revenue
- 8.10.3 Cook Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.10.4 Cook Medical Product Description
- 8.10.5 Cook Medical Recent Development
9 Production Forecasts by Regions
- 9.1 Global Top Embolic Agents Regions Forecast by Revenue (2021-2026)
- 9.2 Global Top Embolic Agents Regions Forecast by Production (2021-2026)
- 9.3 Key Embolic Agents Production Regions Forecast
- 9.3.1 North America
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
10 Embolic Agents Consumption Forecast by Region
- 10.1 Global Embolic Agents Consumption Forecast by Region (2021-2026)
- 10.2 North America Embolic Agents Consumption Forecast by Region (2021-2026)
- 10.3 Europe Embolic Agents Consumption Forecast by Region (2021-2026)
- 10.4 Asia Pacific Embolic Agents Consumption Forecast by Region (2021-2026)
- 10.5 Latin America Embolic Agents Consumption Forecast by Region (2021-2026)
- 10.6 Middle East and Africa Embolic Agents Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Embolic Agents Sales Channels
- 11.2.2 Embolic Agents Distributors
- 11.3 Embolic Agents Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
- 12.1 Market Opportunities and Drivers
- 12.2 Market Challenges
- 12.3 Market Risks/Restraints
- 12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Embolic Agents Study
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Embolic Agents. Industry analysis & Market Report on COVID-19 Impact on Global Embolic Agents is a syndicated market report, published as COVID-19 Impact on Global Embolic Agents Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Embolic Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
